Filing Flows › Praxis Precision Medicines (PRAX) › Recalls, complaints & regulation

Praxis Precision Medicines (PRAX): clinical trials

Praxis Precision Medicines (PRAX) beyond its filings: 8 active clinical trials.

Praxis Precision Medicines' latest quarter

Praxis Precision Medicines, Q4 2024: revenue $7.5M (14× year over year), operating margin -857.0%, net loss $58.7M, operating cash flow −$56.1M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Praxis Precision Medicines have?

8 active studies on ClinicalTrials.gov, 6 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.